Adenoid Cystic Carcinoma
3 competing products in clinical development for Adenoid Cystic Carcinoma.
Pipeline by Phase
Phase 23
All Products (3)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Enfortumab Vedotin | Astellas Pharma | Phase 2 | Recruiting | 42 |
| Lenvatinib | Eisai | Phase 2 | Active | 39 |
| Lenvatinib + Pembrolizumab | Eisai | Phase 2 | Active | 39 |